| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2438 | |||||||||||||||||||||||
| Submitter : | Mrs. Mary Keller | Date & Time: | 12/01/2006 08:12:28 | |||||||||||||||||||||
| Organization : | Mrs. Mary Keller | |||||||||||||||||||||||
| Category : | Drug Industry | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I am pro-life and would like to see future drugs and vaccines (ex. Saars virus or the bird flu) NOT using aborted fetal stem cell lines. I thank you for your support of our fellow unborn humans who, regretably, cannot speak for themselves. | ||||||||||||||||||||||||